MED1 and breast carcinoma: Specifically, the most prevalent kinase fusion genes differed by subtype: MED1::CDK12 in HER2+ breast cancer, PTK2::AGO2 in TNBC, and KAT6B::ADK in HR+/HER2‒ breast cancer (Supplementary Fig. S3b).